Literature DB >> 22535999

GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression.

Robert T Rydze1, Jinhua Xiang, James H McLinden, Jack T Stapleton.   

Abstract

Human immunodeficiency virus (HIV) disease progression is associated with a helper T cell 1 (Th1) to helper T cell 2 (Th2) cytokine profile switch. Persistent GB virus type C (GBV-C) infection is associated with survival and a serum Th1 cytokine profile in HIV-infected individuals. We found that GBV-C infection increased gene expression of Th1 cytokines and decreased Th2 cytokine expression in peripheral blood mononuclear cells. Furthermore, expression of GBV-C NS5A protein in a CD4(+) cell line resulted in upregulation of Th1 cytokines (tumor necrosis factor α) and downregulation of Th2 cytokines (interleukin 4, interleukin 5, interleukin 10, interleukin 13). GBV-C-induced modulation in T-cell cytokines may contribute to the beneficial effect of GBV-C in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535999      PMCID: PMC3415935          DOI: 10.1093/infdis/jis312

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.

Authors:  J Xiang; S Wünschmann; W Schmidt; J Shao; J T Stapleton
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Infection with GB virus C and reduced mortality among HIV-infected patients.

Authors:  H L Tillmann; H Heiken; A Knapik-Botor; S Heringlake; J Ockenga; J C Wilber; B Goergen; J Detmer; M McMorrow; M Stoll; R E Schmidt; M P Manns
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

4.  Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile.

Authors:  Giuseppe Nunnari; Luciano Nigro; Filippo Palermo; Massimo Attanasio; Annemarie Berger; Hans W Doerr; Roger J Pomerantz; Bruno Cacopardo
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

5.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

6.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.

Authors:  Jinhua Xiang; Sarah L George; Sabina Wünschmann; Qing Chang; Donna Klinzman; Jack T Stapleton
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

7.  Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.

Authors:  W Zhang; K Chaloner; H L Tillmann; C F Williams; J T Stapleton
Journal:  HIV Med       Date:  2006-04       Impact factor: 3.180

8.  Regulation of CC chemokine receptor 5 in hepatitis G virus infection.

Authors:  Jacob Nattermann; Hans-Dieter Nischalke; Bernd Kupfer; Jürgen Rockstroh; Lothar Hess; Tilman Sauerbruch; Ulrich Spengler
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

Review 9.  Cytokines and HIV-1: interactions and clinical implications.

Authors:  K Kedzierska; S M Crowe
Journal:  Antivir Chem Chemother       Date:  2001-05

Review 10.  Hepatitis C virus NS5A: tales of a promiscuous protein.

Authors:  Andrew Macdonald; Mark Harris
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more
  7 in total

1.  Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients.

Authors:  Marion C Lanteri; Farnaz Vahidnia; Sylvia Tan; Jack T Stapleton; Philip J Norris; John Heitman; Xutao Deng; Sheila M Keating; Don Brambilla; Michael P Busch; Brian Custer
Journal:  J Infect Dis       Date:  2014-11-25       Impact factor: 5.226

2.  GB virus C coinfections in west African Ebola patients.

Authors:  Michael Lauck; Adam L Bailey; Kristian G Andersen; Tony L Goldberg; Pardis C Sabeti; David H O'Connor
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

Review 3.  GB virus C: the good boy virus?

Authors:  Nirjal Bhattarai; Jack T Stapleton
Journal:  Trends Microbiol       Date:  2012-02-08       Impact factor: 17.079

Review 4.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 5.  Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Authors:  Mehdi Samadi; Vahid Salimi; Mohammad Reza Haghshenas; Seyed Mohammad Miri; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Virol J       Date:  2022-03-09       Impact factor: 4.099

6.  GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.

Authors:  Jack T Stapleton; Kathryn Chaloner; Jeffrey A Martenson; Jingyang Zhang; Donna Klinzman; Jinhua Xiang; Wendy Sauter; Seema N Desai; Alan Landay
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

7.  HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].

Authors:  Kristin Eissmann; Sebastian Mueller; Heinrich Sticht; Susan Jung; Peng Zou; Shibo Jiang; Andrea Gross; Jutta Eichler; Bernhard Fleckenstein; Heide Reil
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.